Unlocking the Therapeutic Potential of a New ‘Dual-Action’ Target for Bone and Joint Diseases

  • Pavlos, Nathan (Chief Investigator)
  • Takayanagi, Hiroshi (Investigator 02)
  • Ng, PeiYing (Investigator 03)
  • Mullin, Benjamin (Investigator 04)
  • Collins, Brett (Investigator 05)
  • Passioura, Toby (Investigator 06)
  • Rackham, Oliver (Investigator 07)

Project Details

StatusActive
Effective start/end date1/01/2331/12/26

Funding

  • National Health & Medical Research Council NHMRC: A$848,048.00